AI assistant
Aarti Drugs Limited — Call Transcript 2023
Jul 18, 2023
62194_rns_2023-07-18_12608fea-489f-400a-a4d7-cde15d98cb8e.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [512 x 106] intentionally omitted <==
Ref: ADL/SE/2023-24/44 July 18, 2023
To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348
Dear Sir/Madam,
Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call
This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts has been scheduled on Monday, July 24, 2023 at 11:00 A.M. IST to discuss the Company’s financial performance for the Quarter ended June 30, 2023. Please find attached herewith invitation for the same.
Kindly take the same on record.
Thanking you,
Yours faithfully,
FOR AARTI DRUGS LIMITED
RUSHIKESH VIVEK DEOLE Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, o=PERSONAL, title=5599, pseudonym=52288d43536c4230831c2e75cd4b8c59, 2.5.4.20=073813c4edff683f8b6ec3cb4e69ca6d8d4f7258a44f635abc18581eaa522821, postalCode=421301, st=Maharashtra, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b575f6fc0484483273dabfc17f, cn=RUSHIKESH VIVEK DEOLE Date: 2023.07.18 21:06:14 +05'30'
RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527
==> picture [468 x 29] intentionally omitted <==
==> picture [287 x 50] intentionally omitted <==
Aarti Drugs Limited Q1 FY24 Earnings Conference Call
DATE & TIME 24[th] July 2023 (Monday) 11:00 am, IST (HK/Singapore 1:30 pm, UK 6:30 am, USA 1:30 am EST)
PARTICIPANTS
Mr. Harshit Savla – Jt. Managing Director Mr. Harit Shah – Executive Director
Mr. Adhish Patil – Chief Financial Officer & Chief Operating Officer
Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited
PRE REGISTRATION LINK – CLICK HERE
CONFERENCE DIAL IN DETAILS
INDIA +91 22 6280 1309 / +91 22 7115 8210 UNITED STATES 1 866 746 2133 UNITED KINGDOM 0 808 101 1573 SINGAPORE 800 101 2045 HONG KONG 800 964 448
RSVP:
Strategic Growth Advisors Pvt. Ltd.
Mr. Deven Dhruva / Mr. Harsh Shah Contact: +91 98333 73300 / +91 97689 74808